Alx Oncology Holdings (ALXO) — Financial Flexibility Index
Alx Oncology Holdings (ALXO) has a Financial Flexibility Index of -0.69x as of March 2026. Free cash flow of $-18.60 Million (operating CF $-18.65 Million minus capex $50.00K) represents -1% of total liabilities ($26.98 Million). Check ALXO strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alx Oncology Holdings Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Alx Oncology Holdings across 8 annual periods. See working capital to net assets of Alx Oncology Holdings to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Alx Oncology Holdings (2018–2025)
Year-by-year free cash flow to debt coverage for Alx Oncology Holdings . For the full company profile including market capitalisation, see Alx Oncology Holdings (ALXO) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.54x | $-83.93 Million | $-84.14 Million | $33.06 Million | ▲ +28.6% |
| 2024 | -3.56x | $-121.47 Million | $-121.91 Million | $34.16 Million | ▼ -45.6% |
| 2023 | -2.44x | $-129.09 Million | $-130.36 Million | $52.84 Million | ▼ -19.7% |
| 2022 | -2.04x | $-87.80 Million | $-89.22 Million | $43.02 Million | ▲ +44.7% |
| 2021 | -3.69x | $-63.18 Million | $-68.10 Million | $17.13 Million | ▲ +40.2% |
| 2020 | -6.16x | $-38.26 Million | $-38.29 Million | $6.21 Million | ▼ -385.6% |
| 2019 | -1.27x | $-13.90 Million | $-14.25 Million | $10.95 Million | ▲ +79.7% |
| 2018 | -6.24x | $-12.54 Million | $-13.19 Million | $2.01 Million | — |